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PREThe efﬁcacies of many antimicrobial peptides are greatly reduced in the presence of high salt concentrations
therefore limiting their development as pharmaceutical compounds. PEM-2-W5K/A9W, a short Trp-rich antimi-
crobial peptide developed based on the structural studies of PEM-2, has been shown to be highly active against
various bacterial strains with less hemolytic activity. Here, correlations between membrane immersion depth,
orientation, and salt-resistance of PEM-2 and PEM-2-W5K/A9W have been investigated via solution structure
and paramagnetic resonance enhancement studies. The antimicrobial activities of PEM-2-W5K/A9W and PEM-
2 against various bacterial and fungal strains including multidrug-resistant and clinical isolates under high salt
conditions were tested. The activities of the salt-sensitive peptide PEM-2 were reduced and diminished at high
salt concentrations, whereas the activities of PEM-2-W5K/A9W were less affected. The results indicated that
the strong salt-resistance of PEM-2-W5K/A9W may arise from the peptide positioning itself deeply into
microbial cell membranes and thus able to disrupt the membranes more efﬁciently.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Current treatments for bacterial and fungal infections are hin-
dered by issues such as ineffective elimination of infections, serious
side effects, and emerging drug resistant microbes. As the prevalence
of bacterial and fungal resistant strains increases signiﬁcantly, it is
urgent to have new alternatives at hands [1]. Antimicrobial peptides
are found to be important in the host innate defense mechanism.
Most of the antimicrobial peptides do not target speciﬁc molecular
receptors, but rather interact and permeabilize microbial mem-
branes [1]. To date, there are thousands of antimicrobial peptides
that have been discovered, characterized, and designed. In vitro
and in vivo studies have shown that these antimicrobial peptides ex-
hibit a wide range of activity against many disease related microbial
organisms [1].
The development of antimicrobial peptides has been hindered
by several problems. One of these major problems is salt sensitivity
[2]. It was found that the efﬁcacy of the antimicrobial peptide
human β-defensin-1 is greatly reduced in the presence of high
salt concentrations in bronchopulmonary ﬂuids in cystic ﬁbrosis
patients [3]. Similar problems were observed in the clinically active5742025; fax:+88635715934.
), jwcheng@life.nthu.edu.tw
ights reserved.histidine-rich peptide P-113, the Trp-rich peptide indolicidins,
gramicidins, bactenecins, and magainins [4–7]. Studies have been
reported on the design of salt-resistant antimicrobial peptides.
However, most of them were focused on overall structure modiﬁ-
cations [2,4,8–12].
Previously, a series of short peptides with improved antimicrobial
activities were designed based on the Trp-rich antimicrobial peptide
PEM-2 (KKWRWWLKALAKK) [13]. Of these newly designed pep-
tides, PEM-2-W5K, with Trp5 of PEM-2 replaced by Lys, was found
to have similar MIC values compared with those of PEM-2 but
possesses a lower human red blood cell hemolytic activity [14].
PEM-2-W5A/A9W, with residues Trp5 and Ala9 of PEM-2 swapping
positions, has 2–8 times more potent antimicrobial activities than
PEM-2. However, an increase of hemolysis of human red blood cells
was also found. PEM-2-W5K/A9W, with Trp5 and Ala9 replaced by
Lys and Trp, was then designed based on the studies of PEM-2,
PEM-2-W5K, and PEM-2-W5A/A9W [14].
Although PEM-2-W5K/A9W is highly active against various bac-
terial strains and possesses less hemolytic activity, many questions
still remain to be elucidated. For example, what are the changes of
the structural features between PEM-2-W5K/A9W and PEM-2? Are
these structural changes affecting the peptide-membrane interac-
tion hence affecting its antimicrobial activities under high salt
conditions? Can we design new types of Trp-rich antimicrobial
peptides based on the structural and peptide-membrane interac-
tion studies of PEM-2 and PEM-2-W5K/A9W? Information about
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depth and orientation of antimicrobial peptides can be obtained
by measuring paramagnetic relaxation enhancement (PRE) using
various paramagnetic compounds. For example, the orientation of
the α-helical peptide CM-15 in DPC micelles was accurately mea-
sured via experimental PREs using the water-soluble paramagnetic
relaxation agent gadolinium-diethylenetriamine pentaacetic acid-
bismethylamideGd(DTPA-BMA) [15]. On the other hand, the position-
ing of the peptides in the interior of the DPC micelle can be mea-
sured using the paramagnetic probe 16-doxylstearic acid [16,17].
Broadening and decreasing of NMR signals can be observed from
residues outside the micelle in the presence of Gd(DTPA-BMA), or
deeply buried in the micelle in the presence of 16-doxylstearic acid. In
here, we have used solution NMR and paramagnetic relaxation enhance-
ment techniques to study the structural features of PEM-2-W5K/A9W
and DPC micelle interactions. The results are compared with the pep-
tide–micelle interactions of the parent peptide PEM-2. Moreover, the an-
timicrobial activities of PEM-2-W5K/A9W against various bacterial and
fungal strains including multidrug-resistant and clinical isolates under
high salt conditions are tested. Correlations between membrane immer-
siondepth, orientation, and salt resistance of these peptides are discussed.
2. Materials and methods
2.1. Sample preparation
All of the peptide sampleswere purchased fromSynBioSci (Livermore,
CA). The identity of the peptides was checked by electrospray mass
spectroscopy and the purity (N95%) was assessed by HPLC. Peptide
concentration was determined by using the UV spectrophotometer
at 280 nm. All of the samples were prepared from a stock solution
containing PEM-2 or PEM-2-W5K/A9W. In addition, d38-DPC and
paramagnetic agents were prepared from stock solutions. The pep-
tides, micelles, and paramagnetic agents were divided into equal
amounts in NMR tubes for experiments so that no errors in attenua-
tion factors due to concentration effects occurred.
2.2. NMR Spectroscopy and Structural Calculations
All NMR experiments were performed on a Bruker Avance 600 MHz
spectrometer at 37 °C using a 2 mM sample. NOESY spectra were ac-
quired at four different mixing times of 60, 90, 120, and 250 ms.
TOCSY spectra were recorded using the MLEV17 pulse sequence with
mixing times of 35 and 70 ms at 2048 points in t2 and 512 points in
t1. All chemical shifts were referenced to internal 2,2-dimethyl-2-
silapentane-5-sulfonate (DSS).
To avoid spin diffusion problems, distance restraints were acquired
from NOEs assigned in a 2D NOESY spectrum with 60 ms mixing time.
The NOE cross-peak intensities were classiﬁed as strong, medium, and
weak, corresponding to distance limits of 1.8–2.8 Å, 2.8–3.6 Å, and
3.6–5.0 Å, respectively. Structural calculations were carried out with
the programs CNS 1.2 (A. T. Brünger, Yale University) on a workstation.
The ﬁnal 20 structures contained no distance constraint violations
greater than 0.2 Å. An average structure was calculated by averaging
the 20 structures, which was reﬁned using the reﬁne.inp protocol as
mentioned above. The structures were analyzed with MOLMOL and
PROCHECK-NMR [18].
2.3. Paramagnetic relaxation enhancements
The localizations of peptides in DPC micelles were studied by two
spin labeled paramagnetic compounds 16-doxyl-stearic acid (16-DSA),
and gadolinium-diethylenetriamine pentaacetic acid-bismethylamide,
Gd(DTPA-BMA). Paramagnetic probes induced resonance perturbation
experiments were performed by acquiring 2-D 1H–1H TOCSY spec-
tra (mixing time = 70 ms) in the absence and presence of 2 mMparamagnetic agents. Cross-peak intensities in the ﬁngerprint region
were compared. The results are reported in terms of the remaining
amplitudes (RA) of the cross-peaks, deﬁned as RA = A(probe)/
A(0), where A(probe) is the amplitude of the cross-peak measured
when the paramagnetic agent is added and A(0) is the amplitude
in the absence of the paramagnetic agent. TOCSY spectra and
Gd(DTPA-BMA) attenuated TOCSY spectra of PEM-2 and PEM-2-
W5K/A9W are provided in supplementary materials to illustrate
the attenuation of the paramagnetic agents.
2.4. Saturation transfer difference studies
For STD-NMR studies, 2 mMpeptideswere added in 20 mMsodium
phosphate buffer in D2O. DPC was saturated at 1.325 ppm (40.0 ppm
for reference) with a cascade of 40 selective Gaussian-shaped pulses
(49 ms each) in an interval of 1 ms resulting in total saturation time
of 0.5 s in one- and two-dimensional STD experiments. 2D Saturation
transfer difference TOCSY spectra were used to detect cross-peaks
between the fatty acyl chains of DPC micelles and the aromatic protons
of peptides. As a control, 1D and 2D STD experiments were performed
by using an identical experimental setupwith the same peptide concen-
tration but in perdeuterated dodecylphosphocholine (d38-DPC).
2.5. Bacterial and fungal strains
Escherichia coli strain (ATCC 25922), Staphylococcus aureus subsp
strain (ATCC 25923, methicillin-resistant), Staphylococcus aureus subsp
strain (ATCC 29213, methicillin-resistant), Staphylococcus aureus subsp
strain (ATCC 19636, methicillin-resistant), Pseudomonas aeruginosa
Migula strain (ATCC 27853, ampicillin-resistant) and Pseudomonas
aeruginosa Migula strain (ATCC 9027, ampicillin-resistant) were used
to test the antibacterial activity of the peptides. Fungal strains from
American Type Culture Collection and clinical isolates were used in
the anti-Candida experiments. Species identiﬁcation of the clinical
yeast strains has previously been described [6].
2.6. Antimicrobial assays
The antibacterial activities of P-113, PEM-2, and PEM-2-W5K/
A9W were determined by the standard broth microdilution method of
National Committee for Clinical Laboratory Standards with Mueller–
Hinton broth and LYM broth. The anti-Candida activities of ﬂuconazole,
P-113, PEM-2, and PEM-2-W5K/A9Wwere determined in LYM broth
media with different salt concentrations. The LYM broth contains
5.4 mM KCl, 5.6 mM Na2HPO4, 0.5 mM MgSO4, and 1.0 mM sodium
citrate [5]. In addition, 0.4 mg of ZnCl2, 2.0 mg of FeCl3·6H2O, 0.1 mg
of CuSO4·5H2O, 0.1 mg of MnSO4·H2O, 0.1 mg of Na2B4O7·10H2O,
700 mg of amino acid mixtures without tryptophan (Clontech), and
20 mg of L-Tryptophanwere added per liter of medium. A vitaminmix-
ture (100×, Sigma) and glucose at ﬁnal concentration of 2% were also
added. The MIC value is the lowest concentration of peptide at which
there was no change in optical density. All tests were measured in
triplicate. The MIC values were converted to a color scale and displayed
using the TreeView Program [19,20]. The hemolytic activities of the
peptides were determined from hemolysis against human red blood
cells (hRBC) as described previously [21].
3. Results
3.1. Structure calculation and description
Two-dimensional 1H NMR was used to study the structure PEM-
2-W5K/A9W in d38-DPC micelles. The chemical shift assignments of
PEM-2-W5K/A9W (2 mM) in 20 mM sodium phosphate buffer
(pH 4.5) and in d38-DPC (120 mM) at 37 °C were performed by the
standard sequential assignment procedures [22]. Assignments of all
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and NOESY spectra. DQF-COSY was used to assign the Hδ and Hγ in
residues. Many of the chemical shifts observed deviated signiﬁcantly
from the random coil values. A total of 385 NOE-derived distance
constraints, including 216 intraresidue, 97 sequential, and 72 medi-
um range distance restraints were used in the structure calculations.
Among these 385 NOEs, there are 28 redundant NOEs. The overlay of
the backbone atoms for the 20 lowest energy structures of PEM-2-
W5K/A9W in d38-DPC is shown in Fig. 1A. Fig. 1B shows the ﬁnal reﬁned
averaged structure of PEM-2-W5K/A9W. The electrostatic surface plots
of PEM-2-W5K/A9W computed usingMOLMOL is shown in Fig. 1C to il-
lustrate the charge distribution of PEM-2-W5K/A9W. The energetic and
structural statistics are listed in Table 1. The RMSD calculated from the
averaged coordinates for PEM-2-W5K/A9W is 0.26 Å for the backbone
heavy atoms (N, C, and Cα) and 1.32 Å for all heavy atoms. Analysis of
ϕ and ψ backbone angles is facilitated by using the program Procheck
NMR [18]. 91.4% of the residues are within most favored regions
and 8.6% of the residues are in additional allowed regions of the
Ramachandran plot indicating the correctness of the structure.
The d38-DPCmicelle-bound structure of PEM-2-W5K/A9W is similar
to the structure of PEM-2 [14] and displays a helical structure with an
apparent amphipathic conformation. A cationic amphipathic structureFig. 1. Calculated structures of PEM-2-W5K/A9W. (A) Stereo-view of 20 lowest energy structu
A9W. Positive charged residues are labeled in blue, tryptophan residues are labeled in brown
W5K/A9W. Positive charge is colored in blue and neutral charge is colored in white.would be best suited formaximizing both electrostatic and hydrophobic
interactions with a membrane. The positively charged residues (Lys1,
Lys2, Arg4, Lys5, Lys8, Lys12, and Lys13) form a hydrophilic patch. Hy-
drophobic residues including Trp3, Trp6, Leu7, Trp9, Leu10, and Ala11
form a hydrophobic face.
In addition to the NMR studies, we have conducted circular dichro-
ism (CD) studies of PEM-2 and PEM-2-W5K/A9W under low and high
salt conditions in solution (Supplementary materials). The peptide–
micelle interactions of PEM-2 and PEM-2-W5K/A9W under low and
high salt conditions were also studied by CD. The CD results indicated
that there were no apparent structural changes for both PEM-2 and
PEM-2-W5K/A9W in solution or in the peptide–micelle interactions
under low and high salt conditions. Hence, the membrane insertion
depth of PEM-2 and PEM-2-W5K/A9W may not change under various
salt concentrations. The salt dependence of peptide self-association in
solution and in peptide–micelle interactions for both PEM-2 and PEM-
2-W5K/A9W was further studied by 1D NMR linewidth analysis with
peptide concentrations ranging from 0.2 mM to 2 mM. There were no
noticeable linewidth changes for both peptides under low and high
salt conditions in solution. Similarly, no apparent line width changes
were found for both peptides in peptide–micelle interactions under
low and high salt conditions.res calculated for PEM-2-W5K/A9W. (B) Final reﬁned average structure for PEM-2-W5K/
, and hydrophobic residues are labeled in gray. (C) Electrostatic surface plot of PEM-2-
Table 1
Summary of structural constrains and structure statistics.
NOE restraints 385
Intraresidues (|i–j| = 0) 216
Sequential (|i–j| = 1) 97
Medium range (2≦|i–j|≦4) 72
Energy statistics (kcal/mol)
Overall 83.84 ± 3.31
Bonds 5.03 ± 0.38
Angles 32.89 ± 1.12
Improper 5.27 ± 0.36
VDW 21.65 ± 5.02
NOE 19.01 ± 1.94
RMSD for geometrical analysis
Interatomic distances (Å) 0.0042 ± 0.000141
Interatomic angles (degree) 0.643 ± 0.008485
Impropers (degree) 0.465 ± 0.001414
Structural statistics (20 structures)
NOE violations, number N0.2 (Å) 0
Atomic RMSD for peptide
All heavy atoms 1.32 ± 0.1
Backbone 0.26 ± 0.37
Ramachandran statistics
Most favored region (%) 91.4
Additionally allowed (%) 8.6
Generously allowed (%) 0
Disallowed (%) 0
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The orientation of PEM-2 and PEM-2-W5K/A9W in d38-DPCmicelles
studied by PRE experiments is shown in Fig. 2A. Peak amplitude changes
of the NH/Hα cross peaks of the TOCSY spectra of PEM-2 and PEM-2-
W5K/A9W in the presence and absence of Gd(DTPA-BMA) and 16-
doxylstearic acid are shown in Fig. 2B and C. In general, the remaining
cross peak amplitudes of PEM-2 in the presence of Gd(DTPA-BMA) are
less than those of PEM-2-W5K/A9W. The remaining cross peak ampli-
tudes of PEM-2 in the presence of 16-doxylstearic acid are larger than
those of PEM-2-W5K/A9W. These results indicate that PEM-2 is located
at the micelles and water interface, whereas PEM-2-W5K/A9W is
inserted deeper into the hydrophobic core of the micelles than PEM-2
is inserted. Based on the PRE studies, the position of each Hα proton
and hence the orientation angles of PEM-2 and PEM-2-W5K/A9W can
be found to be locatedwithin a certain range of degrees onto the surface
of d38-DPC-micelles using the program MOLMOL (Fig. 2A).
3.3. Immersion depth in DPC via NOE constraints
Although the orientations of PEM-2 and PEM-2-W5K/A9W on DPC
micelles can be determined to a certain degree of accuracy via PRE
studies, the immersion depths are needed to be further constrained.
Previously, a solution NMR method was developed to determine the
orientation of the transmembrane helical peptide TM7 and the antimi-
crobial peptide CM15 by ﬁtting of the PRE results to the micelle center
position [15,23]. Other approach was to measure intermolecular trans-
fer NOE signals between the fatty acyl chain of LPC and the micelle-
bound peptide [24]. For PEM-2, intermolecular NOEs were found
between the aromatic protons of Trp3, Trp6, and the fatty acyl chain
protons of DPC (Fig. 3A). Trp3 and Trp6 are located on the hydrophobic
face of PEM-2, whereas Trp5 is located on the hydrophilic face. No
intermolecular NOE was detected between Trp5 and the fatty acyl
chain protons of DPC. Thus, Trp5 was placed at least 5 Å away from
the ﬁrst CH2 group of DPC using the program MOLMOL. For Trp6,
no NOE was detected between the Hε1 proton of the aromatic ring
and the fatty acyl chain protons of DPC. For PEM-2-W5K/A9W,
intermolecular NOEs were found between the fatty acyl chain pro-
tons of DPC and the aromatic protons of Trp3 (except Hε1), Trp6,
and some of the aromatic protons of Trp9 (Hε3, Hξ3, and Hη2)
(Fig. 3B). The aromatic protons of Trp3, Trp6, and Trp9 with NOEswere then placed within 5 Å from the CH2 protons of DPC using the
program MOLMOL. By using these NOE restraints and the peak am-
plitude changes from the PRE experiments, the immersion depths
and orientation angles of PEM-2 and PEM-2-W5K/A9W can be deter-
mined. Cross-peaks found between the fatty acyl chain protons of
DPC micelles (1.325 ppm) and the aromatic protons of tryptophans
of PEM-2 and PEM-2-W5K/A9W were listed in Fig. 3C. In addition
to the NOEs between the aromatic protons of tryptophans and the
acyl chain protons of DPC, we have also observed peaks between
water molecules and the NH protons of Lys1, Lys2, and Hε1 proton
of Trp5 of PEM-2, and the NH protons of Lys1, Lys2, and Lys5 of
PEM-2-W5K/A9W on the hydrophilic face (data not shown). These
peaks may arise probably due to chemical exchange between these
labile protons and water.
3.4. Conﬁrmation of orientation and immersion depth via saturation
transfer difference (STD) NMR studies
STD NMR has been used for a variety of systems including whole
viruses, intact cells, micelles, and membrane proteins [25–27]. In here,
the intermolecular NOEs between PEM-2, PEM-2-W5K/A9W, and DPC
micelles were further conﬁrmed by saturation transfer difference NMR
studies. Based on differences between two-dimensional STD TOCSY
spectra (on resonance and off resonance), the signals arising from the
fatty acyl chain protons of DPC micelles to the aromatic protons of
tryptophans of PEM-2 (Fig. 4A) and PEM-2-W5K/A9W (Fig. 4B) were
identiﬁed. For PEM-2, cross peaks were found for Hδ1, Hε3, Hξ2, Hξ3,
Hη2 and aromatic protons of Trp3, Hξ3, Hη2 and aromatic protons of
Trp5, and Hδ1, Hε3, Hξ2, Hξ3, Hη2 and aromatic protons of Trp6. For
PEM-2-W5K/A9W, cross peaks were found for Hδ1, Hε3, Hξ2, Hξ3,
Hη2 and aromatic protons of Trp3, Trp6, and Trp9. No cross peak was
found for Hε1 of the tryptophans of PEM-2 and PEM-2-W5K/A9W due
to the labile character of these protons under D2O experimental condi-
tions. The immersion depth and orientation of PEM-2 and PEM-2-
W5K/A9W can be determined by combining the results of PRE, NOE,
and STD NMR studies using the program MOLMOL (Fig. 5). In Fig. 5,
peptides are drawn as ball-and-stick models. Aromatic protons of
tryptophans with both NOE and STD cross peaks are represented with
red atoms. Aromatic protons of tryptophans with only STD cross peaks
are representedwith cyan atoms. The results from STD studies matched
well with the PRE and intermolecular NOE results.
3.5. Hydrophobic surface areas under DPC micelles
In addition to the immersion depth of PEM-2 and PEM-2-W5K/A9W,
we have calculated the hydrophobic surface area buried under DPC
micelles for PEM-2 and PEM-2-W5K/A9W using the software PyMol.
The results indicate that the hydrophobic surface area for PEM-2 buried
under DPC micelles is 584.093 Å2, whereas the hydrophobic surface
area for PEM-2-W5K/A9W buried under DPC micelles is 847.654 Å2.
The difference of the hydrophobic surface area buried under DPC
micelles between PEM-2 and PEM-2-W5K/A9W is 263.561 Å2. Howev-
er, the surface area of Ala is 69.707 Å2, and the surface area of Trp is
166.116 Å2. The difference of the surface area between Ala and Trp is
96.409 Å2. Thus, the increase of the hydrophobic surface area buried
under DPC micelles cannot be attributed only to the replacement of
Ala9 with Trp9 in PEM-2-W5K/A9W. It seems that the replacement of
Ala9 with Trp9 causes an overall effect on the hydrophobic interactions
between the peptide and the acyl chains of DPC micelles and hence
makes the peptide buried deeply into the micelles.
3.6. Antimicrobial activities under high salt conditions
PEM-2 and P-113 were used for comparison to demonstrate the ef-
ﬁcacy of PEM-2-W5K/A9W against various bacterial and fungal strains
under high salt conditions. The MIC values of PEM-2-W5K/A9W were
Fig. 2. (A) Immersion depths and orientations of PEM-2 and PEM-2-W5K/A9W buried under DPC micelles. (B) Remaining amplitudes of the NH/Hα cross-peaks in the TOCSY spectra of
PEM-2(●) and PEM-2-W5K/A9W(○) in 120 mMd38-DPC and 2 mMGd(DTPA-BMA). (C) Remaining amplitudes of theNH/Hα cross-peaks in the TOCSY spectra of PEM-2(●) and PEM-2-
W5K/A9W (○) in 120 mM d38-DPC and 2 mM 16-doxyl-stearic acid. Missing data points are due to overlapped cross-peaks in the TOCSY spectra.
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a slightly increase of hemolysis of human red blood cells. Several studies
reported that the efﬁcacy of P-113 is greatly reduced in the presence of
high salt concentrations [28,29]. As can be found from Fig. 6, PEM-2-
W5K/A9W, PEM-2, and P-113 all demonstrate activities against variousbacteria strains in the LYM broth media. However, the activity of P-113
and PEM-2 was reduced by the addition of 50 mM NaCl or 0.5 mM
MgCl2 into the LYM medium and was further diminished by the addi-
tion of 200 mM NaCl or 1.5 mM MgCl2. On the other hand, the MIC
values of PEM-2-W5K/A9W were found to be more potent than PEM-
Fig. 4. Saturation transfer difference NMR spectra used to detect cross-peaks between the fatty acyl chains of DPC micelles and the aromatic protons of PEM-2 (A) and PEM-2-W5K/A9W (B).
Fig. 3. Intermolecular NOEs between the fatty acyl chains of DPC micelles which resonated at 1.325 ppm and the aromatic protons of PEM-2 (A) and PEM-2-W5K/A9W (B). Cross-peaks
found between the fatty acyl chain protons of DPC micelles (1.325 ppm) and the aromatic protons of tryptophans were listed (C).
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Fig. 5. Immersion depths and orientations of PEM-2 and PEM-2-W5K/A9W buried under DPC micelles based on the PRE, NOE, and STD studies. The hydrophobic surface area for PEM-2
buried under DPC micelles is 584.093 Å2, whereas the hydrophobic surface area for PEM-2-W5K/A9W buried under DPC micelles is 847.654 Å2. Peptides are drawn as ball-and-stick
models. Aromatic protons of tryptophanswith both NOE and STD cross peaks are representedwith red atoms. Aromatic protons of tryptophanswith only STD cross peaks are represented
with cyan atoms.
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media (Fig. 6). PEM-2-W5K/A9Wstill retained its antibacterial activities
with 300 mM NaCl or 2.5 mMMgCl2 added.Fig. 6. MIC (anti-bacteria) values displayed on a color scale for Ampicillin (AP), P-113,
PEM-2 and PEM-2-W5K/A9W under different concentrations of NaCl.The anti-Candida activities of ﬂuconazole, P-113, PEM-2, and PEM-
2-W5K/A9W were determined in LYM culture media under different
salt conditions. There were six resistant strains with high ﬂuconazole
MICs (≥32 μg/ml). As expected, P-113, PEM-2, and PEM-2-W5K/
A9W all had similar MICs in the LYM medium, ranging from 1.56 to
6.25 μg/ml against yeast pathogens (or Candida species) (Fig. 7).
The activity of P-113 was inhibited by the addition of 100 mM NaCl
in the LYM medium and that was strongly blocked by the addition
of 150 mM NaCl. Similarly, the activity of PEM-2 was reduced with
the concentration of NaCl greater than 100 mM. Again, PEM-2-
W5K/A9W retained highly active antifungal activities in the media
containing 150 mM NaCl (Fig. 7).
4. Discussion
Hydrophobicity has been known as a key factor in the design andde-
velopment of effective antimicrobial peptides. For example, the number
and location of hydrophobic residues, as well as their hydrophobicity
and type of hydrophobe are important factors that can affect the antimi-
crobial activities of amphipathic α-helical peptides [30,31]. In addition,
a balance of the hydrophobicity and charge distribution of antimicrobial
peptides can generate effective antibacterial activities without cytotox-
icity to mammalian cells [32]. However, less has been addressed in the
involvement of hydrophobicity in the development of salt-resistant an-
timicrobial peptides.
Recently we have developed an easy strategy to increase salt
resistance of antimicrobial peptides by replacing tryptophan or histi-
dine residues with the bulky amino acid β-naphthylalanine [6]. The
β-naphthylalanine replacements may help these peptides to pene-
trate deeper into the bacterial and fungal cell membranes, hence
making these peptides more efﬁcient in disrupting the membranes.
However, relationships between the increased hydrophobic surface
areas of the non-natural amino acids, membrane immersion depth,
orientation, and salt-resistance of these peptides are still unknown.
In this study, we have determined the solution structure of the Trp-
rich antimicrobial peptide PEM-2-W5K/A9W, and studied its para-
magnetic relaxation enhancement in DPC micelles. The solution
structure of PEM-2-W5K/A9W is very similar to the structure of
PEM-2. Thus, the replacements of the amino acids did not change
the peptide backbone structure. PRE and NOE studies indicate that
PEM-2-W5K/A9W can insert more deeply into the DPC micelles
Fig. 7.MIC (anti-Candida) values displayed on a color scale for ﬂuconazole, P-113, PEM-2 and PEM-2-W5K/A9W under different concentrations of NaCl.
2727H.-Y. Yu et al. / Biochimica et Biophysica Acta 1828 (2013) 2720–2728and possess a larger buried hydrophobic surface than its parent pep-
tide PEM-2. Similar to the β-naphthylalanine substitutions [6], the
replacement of Trp5 and Ala9 by Lys and Trp of PEM-2 makes PEM-
2-W5K/A9W to have a larger hydrophobic surface buried under
DPC micelles. These results showed a direct relationship between
membrane-bound surface area and salt-resistance of antimicrobial
peptides. This correlationmay be useful to design salt-resistant antimi-
crobial peptides. For example, membrane-bound surface area can be
increased by replacing tryptophan or histidine residues with non-
natural bulky amino acids [33,34], by adding hydrophobic oligopeptide
end tags [35–37], or by adding fatty acid, vitamin E, or cholesterol to the
termini of antimicrobial peptides [19,38–41].
Increasing hydrophobicity of antimicrobial peptides also leads
to a higher hemolytic activity. This has been observed in the β-
naphthylalanine substituted Trp-rich antimicrobial peptides [33,34]
and other studies [31]. This problem may be compensated by in-
creasing the positive charge residues on the hydrophilic face of the
antimicrobial peptides [31]. To test this idea, we have studied PEM-
2-W5A/A9W, with only Trp5 and Ala9 swapping positions. PEM-2-
W5A/A9W demonstrates similar salt-resistance in comparison with
PEM-2-W5K/A9W (data not shown). This may be due to the fact
that Ala9 in the hydrophobic face was replaced by a larger Trp residue
in both peptides. However, PEM-2-W5A/A9W has a higher hemolytic
activity than PEM-2-W5K/A9W has. The only difference is there is a
Lys instead of an Ala residue on the hydrophilic face of PEM-2-W5K/
A9W. Similar result has been observed where the number and location
of positively charged residues on the hydrophilic face can have a large
effect on hemolytic and antimicrobial activities [31].
With the emergence of antibiotic resistant microbes, the need for
the development of novel therapeutics has become an increasingly
important issue. Certain antimicrobial peptides containing potent
and broad-spectrum activities against various microbial pathogens
are already in clinical trials [1]. However, the antimicrobial activities
of some agents were found to diminish under physiological and high
salt conditions [11,42,43]. In this study, the Trp-rich peptide, PEM-2-
W5K/A9W, has potent activity against microbial pathogens, includingmethicillin, ampicillin, and ﬂuconazole resistant strains. Moreover, the
antimicrobial activity is no longer hindered by high salt concentrations.
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